Datasets

To find datasets from LINCS publications, type the relevant PMID in the datasets search box below.

HMS Dataset ID Dataset Title HMS Dataset Type
20164
CI-1033 KINOMEscan-2
 KINOMEscan
20153
CI-1040 KINOMEscan
 KINOMEscan
20028
CP466722 KINOMEscan
 KINOMEscan
20188
CP-690550 KINOMEscan
 KINOMEscan
20029
CP724714 KINOMEscan
 KINOMEscan
20200
Crizotinib KINOMEscan-2
 KINOMEscan
20082
CYT387 KINOMEscan
 KINOMEscan
20131
Dabrafenib KINOMEscan
 KINOMEscan
20196
Dasatinib KINOMEscan
 KINOMEscan
20210
DCC-2036 KiNativ -- single dose experiment
 KiNativ
20373
DGE-seq Gene expression data for 7 breast cancer cell lines treated with abemaciclib, palbociclib, ribociclib at 0.1, 0.3, 1, or 3 μM, or alvocidib at 0.1 or 1 μM for 6 hours
 RNA-Seq
20128
Dinaciclib KINOMEscan
 KINOMEscan
20296
EGF-induced FoxO3a nuclear-cytoplasmic pulsing dynamics in mammary epithelial cell lines following treatment with increasing doses of a MEK inhibitor. Dataset 1 of 3: single-cell reporter measurements.
 Microscopy/Imaging
20297
EGF-induced FoxO3a nuclear-cytoplasmic pulsing dynamics in mammary epithelial cell lines following treatment with increasing doses of a MEK inhibitor. Dataset 2 of 3: single-cell reporter pulsing metrics.
 Analysis
20298
EGF-induced FoxO3a nuclear-cytoplasmic pulsing dynamics in mammary epithelial cell lines following treatment with increasing doses of a MEK inhibitor. Dataset 3 of 3: mean reporter pulsing metrics.
 Analysis
20337
ERK5-IN-1 KINOMEscan
 KINOMEscan
20160
Erlotinib KINOMEscan
 KINOMEscan
20364
Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values.
 Microscopy/Imaging
20365
Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics.
 Analysis
20366
Evaluation of the sensitivity of two triple-negative breast cancer cell lines (HCC1806, HCC70) to a collection of dual mTOR and PI3K-like kinase (PIKK) inhibitors. Dataset 1 of 2: GR values.
 Microscopy/Imaging
20367
Evaluation of the sensitivity of two triple-negative breast cancer cell lines (HCC1806, HCC70) to a collection of dual mTOR and PI3K-like kinase (PIKK) inhibitors. Dataset 2 of 2: GR metrics.
 Analysis
20193
Flavopiridol KINOMEscan
 KINOMEscan
20287
FoxO3a nuclear-cytoplasmic pulsing dynamics in a mammary epithelial cell line following growth-factor treatment with varying ERK/AKT activation loads. Dataset 1 of 3: single-cell reporter measurements.
 Microscopy/Imaging
20288
FoxO3a nuclear-cytoplasmic pulsing dynamics in a mammary epithelial cell line following growth-factor treatment with varying ERK/AKT activation loads. Dataset 2 of 3: single-cell reporter pulsing metrics.
 Analysis
20289
FoxO3a nuclear-cytoplasmic pulsing dynamics in a mammary epithelial cell line following growth-factor treatment with varying ERK/AKT activation loads. Dataset 3 of 3: mean reporter pulsing metrics.
 Analysis